Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 14 February 2020. Anne Schuchat.

Executive Summary

The US Centers for Disease Control and Prevention (CDC) developed a diagnostic test relatively quickly after news hit that a new coronavirus is spreading across China. Now top health officials say diagnostic manufacturers should help scale up the production of these tests. See what Anne Schuchat, principal deputy director of the CDC, said about it here. 

“The CDC has actually posted the sequences of the viruses that we’ve gotten from cases here in the US, but we’ve also prepared viral isolates that can be ordered by research companies.” – Anne Schuchat, principal deputy director, CDC

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126243

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel